Navigation

Investiment.io
Financial analysis platform

Bristol-Myers Squibb Company

BMY โ€ข NYSE

$63.33
โ–ผ0.10 (0.16%)โ€ข REGULAR

Bristol-Myers Squibb Company

$63.33
โ–ผ0.2%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading

๐Ÿ“ˆ Advanced DCF Valuation

Professional-grade discounted cash flow analysis with scenario modeling for BMY

Healthcare โ€ข Drug Manufacturers - General โ€ข Market Cap: $129,656,364,260.33

Scenario Analysis

Compare different scenarios to understand valuation sensitivity

๐Ÿ”ป-100.0% upside

Conservative Case

$0.00

๐Ÿ“Š-97.1% upside

Base Case

$1.87

๐Ÿ”บ-91.9% upside

Optimistic Case

$5.12

๐Ÿ’ฐMarket Price

Current Price

$63.43

DCF Model & Results

Detailed cash flow projections and valuation analysis

๐Ÿ’ต Enhanced Cash Flow Projections

YearRevenueGrowth %Operating Margin %NOPATCapExFCFPV of FCF
1$50,603,700,000.005.0%15.0%$5,996,538,450.00$1,410,963,750.00$6,091,637,200.00$5,636,388,327.42
2$52,627,848,000.004.0%11.3%$4,677,299,991.00$1,387,232,028.00$4,858,782,663.00$4,159,692,494.69
3$54,469,822,680.003.5%8.4%$3,630,754,118.01$1,360,652,764.35$3,894,986,160.67$3,085,365,002.82
4$56,103,917,360.403.0%6.3%$2,804,757,556.17$1,328,127,479.96$3,151,577,123.61$2,309,912,059.55
5$57,506,515,294.412.5%4.7%$2,156,157,371.30$1,290,078,753.97$2,584,261,086.49$1,752,551,430.25
Terminalโ€”3.0%โ€”โ€”โ€”$32,076,769,292.49$21,753,292,728.51
Enterprise Value$38,697,202,043.24
Net Debt$34,902,000,000.00
Equity Value$3,795,202,043.24
Price per Share$1.87
EV/Revenue (Final Year)0.7x
Terminal Value %56.2%
WACC8.1%

๐Ÿฅ Company Financial Health

Historical Revenue Growth1.0%
Current Operating Margin0.0%
FCF Conversion Rate26.7%
Net Debt/Equity0.00
ROE0.0%
ROIC0.0%
Beta1.20
Interest Coverage0.00
Enhanced DCF data sourced from Financial Modeling Prep (FMP) โ€ข Model incorporates industry best practices and academic research โ€ข Calculations are estimates and should not be used as sole investment advice โ€ข Consult with a financial advisor before making investment decisions